SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030027
Filing Date
2019-08-07
Accepted
2019-08-07 16:01:29
Documents
59
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q scph-10q_20190630.htm 10-Q 1209570
2 EX-31.1 scph-ex311_7.htm EX-31.1 10688
3 EX-32.1 scph-ex321_8.htm EX-32.1 8148
  Complete submission text file 0001564590-19-030027.txt   4851515

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT scph-20190630.xml EX-101.INS 1033197
5 XBRL TAXONOMY EXTENSION SCHEMA scph-20190630.xsd EX-101.SCH 41160
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scph-20190630_cal.xml EX-101.CAL 44876
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scph-20190630_def.xml EX-101.DEF 112394
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE scph-20190630_lab.xml EX-101.LAB 330247
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scph-20190630_pre.xml EX-101.PRE 251177
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38293 | Film No.: 191005367
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1